We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Global Endometrial Ablation Market Driven by Rising Prevalence of Gynecological Disorders

By HospiMedica International staff writers
Posted on 21 Feb 2023
Print article
Image: The demand for endometrial ablation devices is increasing due to rising prevalence of gynecological disorders (Photo courtesy of Pexels)
Image: The demand for endometrial ablation devices is increasing due to rising prevalence of gynecological disorders (Photo courtesy of Pexels)

Gynecological disorders, such as menorrhagia, PCOD, abnormal vaginal bleeding, affect millions of women globally every year and are on the rise. Abnormal Uterine Bleeding (AUB) is the most common disorder among reproductive-aged women that results in loss of productivity and can necessitate surgical intervention. Endometrial ablation is a procedure for reducing severe menstrual bleeding by destroying the endometrium, a thin layer of tissue that lines the uterus. It is now possible to destroy the endometrium in-situ, in a day-care procedure, thanks to advancements in minimally invasive endometrial ablation procedures. Endometrial ablation procedure is less risky and technically simple to perform, as well as more beneficial as they provide patients with less invasive surgical alternatives to hysterectomy.

As a result, the global endometrial ablation market which was valued at USD 3.2 billion in 2020 is expected to grow at a compound annual growth rate (CAGR) of 5.2% over the 2021-2028 forecast period, driven by increasing demand for endometrial ablation procedures as well as devices on account of the rising prevalence of gynecological disorders, and growing public awareness about endometrial ablation. The market growth is also likely to be aided by technological advancements and advantages offered by endometrial ablation over surgical methods. Women’s health has become a priority for governments and private organizations globally. One of the key factors expected to drive the growth of the endometrial ablation market in the developed countries is women's health insurance coverage plans. Increased initiatives with respect to women’s health could drive higher adoption of treatment options available for them, thus boosting market growth. However, some risks associated with endometrial ablation procedures, such as infection, tearing of the uterine wall or bowel, could hamper market growth.

These are the latest findings of Grand View Research (San Francisco, CA, USA), a market research and consulting company.

Based on type, the devices segment dominated the endometrial ablation market in 2020 with a revenue share of more than 70%, driven by an increasing number of women suffering from menorrhagia. There are various techniques and devices, such as radiofrequency ablation where high-energy radio waves are used to destroy the endometrial tissue; cryoablation, where abnormal tissues are frozen and destroyed using an extremely cold liquid or a device called a cryoprobe; balloon therapy, where the endometrium is destroyed by injecting heated fluid into the balloon.

In 2020, radiofrequency ablation dominated the devices segment with a revenue share of 26.3% and is expected to maintain its dominance during the forecast period. The growth of radiofrequency ablation devices is driven by their convenience, speed of treatment, efficacy, and cost-efficiency as compared to other ablation devices. Moreover, radiofrequency ablation devices are commonly available and well-known among physicians. The thermal balloon segment is also expected to grow at a significant pace during the forecast period. Thermal balloon offers a less invasive alternative to hysterectomy and is also hygienic as it utilizes a single-use disposable catheter balloon cartridge and has been approved by the US Food and Drug Administration (FDA) for the treatment of menorrhagia in women.

Based on end use, the hospital segment dominated the endometrial ablation market in 2020 with a revenue share of over 55%, driven by an increase in patients hospitalized for gynecological disorders, as hospitals offer good care and reimbursements. In addition, hospitals have advanced treatment devices, contributing further to the segment’s growth. Moreover, because hospitals are capable of easily managing any problems that can arise while performing surgery and have a wide range of treatment options available, the inflow of patients for gynecological treatments is significantly higher in hospitals as compared to other healthcare settings. On the other hand, the Ambulatory Surgery Center (ASC) segment is expected to register the fastest CAGR during the forecast period, as a result of an increase in the number of ASCs. ASCs offer more cost-effective services and convenient environment, personalized treatment, less waiting time, minimal or no risk of Hospital-Acquired Infections (HAIs), and shorter stay duration. These factors are expected to contribute to the increasing demand for ASCs for endometrial ablation procedures.

Geographically, North America dominated the global endometrial ablation market in 2020 with the largest revenue share of 33.6%, driven by rising cases of gynecological disorders, improvement in healthcare infrastructure, and a strong foundation laid by the top industry players to deliver cutting-edge endometrial ablation devices. In the U.S., patient outcomes and safety are accorded top priority, and various projects have been undertaken to improve healthcare quality and lower costs in the country. North America also has a higher healthcare spending as compared to any other region, thereby contributing to the market growth. In Asia Pacific, the endometrial ablation market is expected to record a significant growth during the forecast period as the region progresses toward its objective of obtaining Universal Health Care, or UHC. Also, an increase in the prevalence of menorrhagia and rising demand for innovative technologies will aid the growth of the Asia Pacific endometrial ablation market.

Related Links:
Grand View Research 

Gold Supplier
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Lesion Tracking Application
Sectra Lesion Tracking
Silver Supplier
Patient Simulator
PatSim 200
IV Medication Safety Software
ICU Medical MedNet IV

Print article
FIME - Informa



view channel
Image: The AI tool can also tackle dangerous inequalities in heart attack diagnosis (Photo courtesy of Freepik)

AI Algorithm Integrates Cardiac Troponin Test Results with Clinical Data to Quickly Rule out Heart Attacks in Patients

The accepted standard for diagnosing myocardial infarction, or heart attack, involves assessing the blood for troponin levels. However, this approach applies the same benchmark for all patients, failing... Read more

Critical Care

view channel
Image: New technology gives patients the power to heal chronic wounds using their own blood (Photo courtesy of RedDress)

POC Solution Creates In Vitro Blood Clots from Patient’s Own Whole Blood in Real-Time to Treat Post-Surgical Wounds

Blood clots are a natural mechanism of the body's healing process. However, for chronic wounds resulting from diabetes and other conditions, blood is unable to reach these areas, hampering the initiation... Read more

Surgical Techniques

view channel
Image: The deployable electrodes are ideal for minimally invasive craniosurgery (Photo courtesy of EPFL)

Soft Robotic Electrode Offers Minimally Invasive Solution for Craniosurgery

Minimally invasive medical procedures offer numerous benefits to patients, including decreased tissue damage and shorter recovery periods. However, creating equipment that can pass through a small opening... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: IntelliSep is the first FDA-cleared diagnostic tool to assess cellular host response to aid in identifying ED patients with sepsis (Photo courtesy of Cytovale)

Rapid Microfluidic Test Demonstrates Efficacy as Diagnostic Aid to Improve Sepsis Triage in ED

Sepsis is the primary cause of mortality worldwide, accounting for over 350,000 fatalities annually in the United States alone, a figure that surpasses deaths from opioid overdoses, prostate cancer, and... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.